Alzheimer’s Research References/Papers: September 2009 4th Week’s: Alzheimer’s Research References/Papers

Alzheimer’s Research References/Papers: September 2009 4th Week’s: Alzheimer’s Research References/Papers


Elsinghorst PW, Härtig W, Goldhammer S, Grosche J, Gütschow M. A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques. Org Biomol Chem. 2009 Oct 7;7(19):3940-6.

Romero K, de Mars M, Frank D, Anthony M, Neville J, Kirby L, Smith K, Woosley RL. The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases. Clin Pharmacol Ther. 2009 Oct;86(4):365-7.

Harrison FE, Allard J, Bixler R, Usoh C, Li L, May JM, McDonald MP. Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice. Nutr Neurosci. 2009 Oct;12(5):203-18.

Lanctôt KL, Hsiung GY, Feldman HH, Masoud ST, Sham L, Herrmann N. Assessing the validity of deriving clinical dementia rating (CDR) global scores from independently-obtained functional rating scale (FRS) scores in vascular dementia with and without Alzheimer's disease. Int J Geriatr Psychiatry. 2009 Oct;24(10):1174-6.

Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci. 2009 Oct;32(10):548-57.

Hedlund E, Perlmann T. Neuronal cell replacement in Parkinson's disease. J Intern Med. 2009 Oct;266(4):358-71.

Fusari A, Molina JA. [Sense of smell, physiological ageing and neurodegenerative diseases: II. Ageing and neurodegenerative diseases.] Rev Neurol. 2009 Oct 1-15;49(7):363-9.

Baquero M, Peset V, Burguera JA, Salazar-Cifre A, Bosca-Blasco ME, Del Olmo-Rodriguez A, Valero-Merino C, Munoz-Lacalle RA, En Nombre Del Nodo Enae Valencia EN. [Quality of life in Alzheimer's disease.] Rev Neurol. 2009 Oct 1-15;49(7):337-42.

Spuch C, Antequera D, Isabel Fernandez-Bachiller M, Isabel Rodríguez-Franco M, Carro E. A New Tacrine-Melatonin Hybrid Reduces Amyloid Burden and Behavioral Deficits in a Mouse Model of Alzheimer's Disease. Neurotox Res. 2009 Sep 23;

Kazanis I. The subependymal zone neurogenic niche: a beating heart in the centre of the brain: How plastic is adult neurogenesis? Opportunities for therapy and questions to be addressed. Brain. 2009 Sep 22;

Zou K, Maeda T, Watanabe A, Liu J, Liu S, Oba R, Satoh YI, Komano H, Michikawa M. Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme. J Biol Chem. 2009 Sep 22;

Goodger ZV, Rajendran L, Trutzel A, Kohli BM, Nitsch RM, Konietzko U. Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J Cell Sci. 2009 Sep 22;


Buccafusco JJ. Emerging cognitive enhancing drugs. Expert Opin Emerg Drugs. 2009 Sep 22;

Boussert S, Diez-Perez I, Kogan MJ, de Oliveira E, Giralt E. An Intramolecular O-N Migration Reaction on Gold Surfaces: Toward the Preparation of Well-Defined Amyloid Surfaces. ACS Nano. 2009 Sep 22;

Sultana R, Banks WA, Butterfield DA. Decreased levels of PSD95 and two associated proteins and increased levels of BCl(2) and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease. J Neurosci Res. 2009 Sep 22;

Latourelle JC, Pankratz N, Dumitriu A, Wilk JB, Goldwurm S, Pezzoli G, Mariani CB, DeStefano AL, Halter C, Gusella JF, Nichols WC, Myers RH, Foroud T, Coordinators PP, Laboratory PP, Coordinators GI, Laboratories GM. Genomewide Association Study for Onset Age in Parkinson Disease. BMC Med Genet. 2009 Sep 22;10(1):98.

Henneman WJ, Vrenken H, Barnes J, Sluimer IC, Verwey NA, Blankenstein MA, Klein M, Fox NC, Scheltens P, Barkhof F, van der Flier WM. Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease. Neurology. 2009 Sep 22;73(12):935-40.

Triebel KL, Martin R, Griffith HR, Marceaux J, Okonkwo OC, Harrell L, Clark D, Brockington J, Bartolucci A, Marson DC. Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study. Neurology. 2009 Sep 22;73(12):928-34.

Ye J, Meng X, Yan C, Wang C. Effect of Purple Sweet Potato Anthocyanins on beta-Amyloid-Mediated PC-12 Cells Death by Inhibition of Oxidative Stress. Neurochem Res. 2009 Sep 22;

Mandal M, Yan Z. PIP2 Regulation of NMDA Receptor Channels in Cortical Neurons. Mol Pharmacol. 2009 Sep 21;

Fossati S, Cam J, Meyerson J, Mezhericher E, Romero IA, Couraud PO, Weksler BB, Ghiso J, Rostagno A. Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid-{beta} variants in cells composing the cerebral vessel walls. FASEB J. 2009 Sep 21;

Yoo MH, Gu X, Xu XM, Kim JY, Carlson BA, Patterson AD, Cai H, Gladyshev VN, Hatfield DL. Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease. Antioxid Redox Signal. 2009 Sep 21;

Fischer D, Mukrasch MD, Biernat J, Bibow S, Blackledge M, Griesinger C, Mandelkow E, Zweckstetter M. Conformational changes specific for pseudo-phosphorylation at Ser262 selectively impair binding of tau to microtubules. Biochemistry. 2009 Sep 21;

Muotri AR, Zhao C, Marchetto MC, Gage FH. Environmental influence on L1 retrotransposons in the adult hippocampus. Hippocampus. 2009 Sep 21;19(10):1002-1007.

Neilson S. On diagnosing Alzheimer dementia. CMAJ. 2009 Sep 21;